{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:37:05Z","timestamp":1782603425045,"version":"3.54.5"},"reference-count":65,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,5,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Monoclonal B-cell lymphocytosis (MBL), a newly recognized entity found in approximately 3% of normal persons, precedes chronic lymphocytic leukemia. However, MBLs progress into overt malignancy only in a very minor portion of cases, thus raising the clinical concern of whether and how we can discriminate at diagnosis which rare cases will evolve into a fully fledged tumor. Understanding the molecular\/biologic features underlying the risk of progression may significantly modify our strategies for correctly managing B-cell premalignant states. MBL cells bear the same chromosomal abnormalities of chronic lymphocytic leukemia. Genome-wide sequencing and animal models indicate that genetic abnormalities disrupting the control of cell growth and survival cooperate with microenvironment-triggered events, mainly represented by antigen-mediated B-cell receptor and coreceptor stimulation, to trigger and fuel clonal expansion. The initial functional activation of survival\/proliferation pathways may later become subsidized by autonomous genetic abnormalities (eg, a single mutation) affecting the same or parallel critical signaling pathway(s).<\/jats:p>","DOI":"10.1182\/blood-2012-01-404681","type":"journal-article","created":{"date-parts":[[2012,3,15]],"date-time":"2012-03-15T04:27:26Z","timestamp":1331785646000},"page":"4358-4362","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":45,"title":["Monoclonal B-cell lymphocytosis: right track or red herring?"],"prefix":"10.1182","volume":"119","author":[{"given":"Paolo","family":"Ghia","sequence":"first","affiliation":[{"name":"Laboratory of B Cell Neoplasia, Division of Molecular Oncology, San Raffaele Scientific Institute, Milan, Italy;"},{"name":"Lymphoma Unit, Department of Onco-Hematology, San Raffaele Scientific Institute, Milan, Italy;"},{"name":"Universit\u00e0 Vita-Salute San Raffaele, Milan, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Caligaris-Cappio","sequence":"additional","affiliation":[{"name":"Lymphoma Unit, Department of Onco-Hematology, San Raffaele Scientific Institute, Milan, Italy;"},{"name":"Universit\u00e0 Vita-Salute San Raffaele, Milan, Italy; and"},{"name":"Laboratory of Lymphoid Malignancies, Division of Molecular Oncology, San Raffaele Scientific Institute, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111808202469600_B1","volume-title":"Classification of Tumours: Tumours of the Haemopoietic and Lymphoid Tissues","author":"World Health Organization","year":"2008","edition":"4th Ed"},{"issue":"21","key":"2019111808202469600_B2","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1182\/blood-2011-01-270140","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies.","volume":"117","author":"Korde","year":"2011","journal-title":"Blood"},{"issue":"22","key":"2019111808202469600_B3","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"issue":"22","key":"2019111808202469600_B4","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","article-title":"A monoclonal gammopathy precedes multiple myeloma in most patients.","volume":"113","author":"Weiss","year":"2009","journal-title":"Blood"},{"issue":"13","key":"2019111808202469600_B5","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance.","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"issue":"9","key":"2019111808202469600_B6","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1182\/blood.V99.9.3376","article-title":"In situ localization of follicular lymphoma: description and analysis by laser capture microdissection.","volume":"99","author":"Cong","year":"2002","journal-title":"Blood"},{"issue":"5","key":"2019111808202469600_B7","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1365-2559.2010.03529.x","article-title":"Intrafollicular neoplasia\/in situ follicular lymphoma: review of a series of 13 cases.","volume":"56","author":"Montes-Moreno","year":"2010","journal-title":"Histopathology"},{"issue":"11","key":"2019111808202469600_B8","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3324\/haematol.2009.013359","article-title":"Mantle cell lymphoma.","volume":"94","author":"Pileri","year":"2009","journal-title":"Haematologica"},{"issue":"3","key":"2019111808202469600_B9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2141.2005.05550.x","article-title":"Diagnostic criteria for monoclonal B-cell lymphocytosis.","volume":"130","author":"Marti","year":"2005","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111808202469600_B10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2008-09-176933","article-title":"The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring.","volume":"114","author":"Dagklis","year":"2009","journal-title":"Blood"},{"issue":"6","key":"2019111808202469600_B11","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood-2003-09-3277","article-title":"Monoclonal CD5+ and CD5\u2212 B-lymphocyte expansions are frequent in the peripheral blood of the elderly.","volume":"103","author":"Ghia","year":"2004","journal-title":"Blood"},{"issue":"1","key":"2019111808202469600_B12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2009-01-197368","article-title":"Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach.","volume":"114","author":"Nieto","year":"2009","journal-title":"Blood"},{"issue":"2","key":"2019111808202469600_B13","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1182\/blood.V100.2.635","article-title":"Monoclonal B lymphocytes with the characteristics of \u201cindolent\u201d chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts.","volume":"100","author":"Rawstron","year":"2002","journal-title":"Blood"},{"issue":"2","key":"2019111808202469600_B14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2141.2010.08339.x","article-title":"Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families.","volume":"151","author":"Goldin","year":"2010","journal-title":"Br J Haematol"},{"issue":"7","key":"2019111808202469600_B15","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood-2002-03-0892","article-title":"Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion.","volume":"100","author":"Rawstron","year":"2002","journal-title":"Blood"},{"issue":"7","key":"2019111808202469600_B16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJMoa0806122","article-title":"B-cell clones as early markers for chronic lymphocytic leukemia.","volume":"360","author":"Landgren","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111808202469600_B17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1056\/NEJMoa075290","article-title":"Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.","volume":"359","author":"Rawstron","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111808202469600_B18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2009.07711.x","article-title":"The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors.","volume":"146","author":"Rossi","year":"2009","journal-title":"Br J Haematol"},{"issue":"24","key":"2019111808202469600_B19","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1200\/JCO.2008.21.2704","article-title":"Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia.","volume":"27","author":"Shanafelt","year":"2009","journal-title":"J Clin Oncol"},{"issue":"25","key":"2019111808202469600_B20","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1182\/blood-2011-05-357251","article-title":"General population low-count CLL-like MBL persist over time without clinical progression, though carrying the same cytogenetic abnormalities of CLL.","volume":"118","author":"Fazi","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2019111808202469600_B21","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/leu.2009.287","article-title":"Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management.","volume":"24","author":"Shanafelt","year":"2010","journal-title":"Leukemia"},{"key":"2019111808202469600_B22","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1002\/cyto.b.20533","article-title":"Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL).","volume":"78","author":"Rawstron","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"issue":"1","key":"2019111808202469600_B23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/leu.2009.192","article-title":"Single-cell analysis reveals oligoclonality among \u2018low-count\u2019 monoclonal B-cell lymphocytosis.","volume":"24","author":"Lanasa","year":"2010","journal-title":"Leukemia"},{"issue":"6","key":"2019111808202469600_B24","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1182\/blood.V99.6.2185","article-title":"Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation.","volume":"99","author":"Avet-Loiseau","year":"2002","journal-title":"Blood"},{"issue":"4","key":"2019111808202469600_B25","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood.V100.4.1417.h81602001417_1417_1424","article-title":"Genomic abnormalities in monoclonal gammopathy of undetermined significance.","volume":"100","author":"Fonseca","year":"2002","journal-title":"Blood"},{"issue":"4","key":"2019111808202469600_B26","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/ijc.23958","article-title":"Prevalence and frequency of circulating t(14;18)-MBR translocation carrying cells in healthy individuals.","volume":"124","author":"Schuler","year":"2009","journal-title":"Int J Cancer"},{"issue":"6","key":"2019111808202469600_B27","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.semcancer.2010.08.005","article-title":"CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it?","volume":"20","author":"Scarfo","year":"2010","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"2019111808202469600_B28","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/leu.2010.305","article-title":"CLL-like B-lymphocytes are systematically present at very low numbers in peripheral blood of healthy adults.","volume":"25","author":"Almeida","year":"2011","journal-title":"Leukemia"},{"issue":"3","key":"2019111808202469600_B29","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1182\/blood-2002-12-3639","article-title":"Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features.","volume":"102","author":"Guarini","year":"2003","journal-title":"Blood"},{"issue":"9","key":"2019111808202469600_B30","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.leukres.2007.11.030","article-title":"MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count: >or= 5 \u00d7 109L\u22121 but a B-cell lymphocyte count <5 \u00d7 109L\u22121?","volume":"32","author":"Shanafelt","year":"2008","journal-title":"Leuk Res"},{"issue":"2","key":"2019111808202469600_B31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3324\/haematol.2010.030189","article-title":"Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group.","volume":"96","author":"Molica","year":"2011","journal-title":"Haematologica"},{"issue":"18","key":"2019111808202469600_B32","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1182\/blood-2008-09-176149","article-title":"B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.","volume":"113","author":"Shanafelt","year":"2009","journal-title":"Blood"},{"key":"2019111808202469600_B33","article-title":"Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines? [published online ahead of print January 30, 2012].","author":"Scarf\u00f2","journal-title":"Leukemia"},{"issue":"7354","key":"2019111808202469600_B34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"issue":"1","key":"2019111808202469600_B35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","article-title":"Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.","volume":"44","author":"Quesada","year":"2012","journal-title":"Nat Genet"},{"issue":"26","key":"2019111808202469600_B36","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.","volume":"365","author":"Wang","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111808202469600_B37","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1182\/blood-2011-09-379966","article-title":"Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.","volume":"119","author":"Rossi","year":"2012","journal-title":"Blood"},{"issue":"7","key":"2019111808202469600_B38","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1084\/jem.20110921","article-title":"Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.","volume":"208","author":"Fabbri","year":"2011","journal-title":"J Exp Med"},{"issue":"27","key":"2019111808202469600_B39","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1200\/JCO.2007.15.4393","article-title":"Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?","volume":"26","author":"Caligaris-Cappio","year":"2008","journal-title":"J Clin Oncol"},{"issue":"6","key":"2019111808202469600_B40","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2796.2008.02030.x","article-title":"Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation.","volume":"264","author":"Ghia","year":"2008","journal-title":"J Intern Med"},{"issue":"1","key":"2019111808202469600_B41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/leu.2009.186","article-title":"A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence.","volume":"24","author":"Darzentas","year":"2010","journal-title":"Leukemia"},{"key":"2019111808202469600_B42","article-title":"Sterotyped B-cell receptors in one-third of chronic lymphocytic leukemia: towards a molecular classification with implications for targeted therapeutic interventions [published online ahead of print March 13, 2012].","author":"Agathangelidis","journal-title":"Blood"},{"issue":"11","key":"2019111808202469600_B43","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2119\/2008-00102.Catera","article-title":"Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation.","volume":"14","author":"Catera","year":"2008","journal-title":"Mol Med"},{"issue":"19","key":"2019111808202469600_B44","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1182\/blood-2009-09-244251","article-title":"Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin.","volume":"115","author":"Chu","year":"2010","journal-title":"Blood"},{"issue":"7","key":"2019111808202469600_B45","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1182\/blood-2007-11-125450","article-title":"A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies.","volume":"111","author":"Lanemo Myhrinder","year":"2008","journal-title":"Blood"},{"issue":"3","key":"2019111808202469600_B46","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1182\/blood-2011-01-329870","article-title":"Lack of TIR8\/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models.","volume":"118","author":"Bertilaccio","year":"2011","journal-title":"Blood"},{"issue":"11","key":"2019111808202469600_B47","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/leu.2011.149","article-title":"The functional in vitro response to CD40 ligation reflects a different clinical outcome in patients with chronic lymphocytic leukemia.","volume":"25","author":"Scielzo","year":"2011","journal-title":"Leukemia"},{"issue":"10","key":"2019111808202469600_B48","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.","volume":"99","author":"Bichi","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"2019111808202469600_B49","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1182\/blood-2009-06-230169","article-title":"Chronic lymphocytic leukemia of Emu-TCL1 transgenic mice undergoes rapid cell turnover that can be offset by extrinsic CD257 to accelerate disease progression.","volume":"114","author":"Enzler","year":"2009","journal-title":"Blood"},{"issue":"18","key":"2019111808202469600_B50","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1182\/blood-2009-12-258814","article-title":"HS1 has a central role in the trafficking and homing of leukemic B cells.","volume":"116","author":"Scielzo","year":"2010","journal-title":"Blood"},{"issue":"17","key":"2019111808202469600_B51","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.","volume":"353","author":"Calin","year":"2005","journal-title":"N Engl J Med"},{"issue":"7","key":"2019111808202469600_B52","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1182\/blood.V97.7.2098","article-title":"Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia.","volume":"97","author":"Migliazza","year":"2001","journal-title":"Blood"},{"issue":"1","key":"2019111808202469600_B53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ccr.2009.11.019","article-title":"The DLEU2\/miR-15a\/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.","volume":"17","author":"Klein","year":"2010","journal-title":"Cancer Cell"},{"issue":"12","key":"2019111808202469600_B54","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1182\/blood-2007-02-071225","article-title":"Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice.","volume":"109","author":"Raveche","year":"2007","journal-title":"Blood"},{"issue":"13","key":"2019111808202469600_B55","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1182\/blood-2011-09-381814","article-title":"Functional dissection of the chromosome 13q14 tumor suppressor locus using transgenic mouse lines.","volume":"119","author":"Lia","year":"2012","journal-title":"Blood"},{"issue":"3","key":"2019111808202469600_B56","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1182\/blood.V98.3.533","article-title":"Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells.","volume":"98","author":"Ghia","year":"2001","journal-title":"Blood"},{"issue":"20","key":"2019111808202469600_B57","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1182\/blood-2010-12-324210","article-title":"A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease.","volume":"117","author":"Bagnara","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2019111808202469600_B58","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ccr.2011.06.029","article-title":"Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia.","volume":"20","author":"Kikushige","year":"2011","journal-title":"Cancer Cell"},{"issue":"6","key":"2019111808202469600_B59","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.semcancer.2010.10.012","article-title":"New insights into the pathogenesis of chronic lymphocytic leukemia.","volume":"20","author":"Klein","year":"2010","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"2019111808202469600_B60","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2141.2008.07475.x","article-title":"Expression and function of toll like receptors in chronic lymphocytic leukaemia cells.","volume":"144","author":"Muzio","year":"2009","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111808202469600_B61","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1172\/JCI23409","article-title":"In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells.","volume":"115","author":"Messmer","year":"2005","journal-title":"J Clin Invest"},{"issue":"10","key":"2019111808202469600_B62","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1002\/ijc.25579","article-title":"Sustained NF-kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locus.","volume":"128","author":"Frenzel","year":"2011","journal-title":"Int J Cancer"},{"issue":"2","key":"2019111808202469600_B63","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","article-title":"The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.","volume":"117","author":"Herishanu","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2019111808202469600_B64","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.semcancer.2010.09.005","article-title":"Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): from understanding the basics towards therapeutic targeting.","volume":"20","author":"Burger","year":"2010","journal-title":"Semin Cancer Biol"},{"issue":"4","key":"2019111808202469600_B65","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1365-2141.2009.07849.x","article-title":"Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia.","volume":"147","author":"Anderson","year":"2009","journal-title":"Br J Haematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/19\/4358\/1352932\/zh801912004358.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/19\/4358\/1352932\/zh801912004358.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T13:41:07Z","timestamp":1574084467000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/19\/4358\/30005\/Monoclonal-Bcell-lymphocytosis-right-track-or-red"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,10]]},"references-count":65,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2012,5,10]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-01-404681","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,10]]}}}